Engrail Therapeutics Revenue and Competitors

Location

#6215

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Engrail Therapeutics's estimated annual revenue is currently $8.2M per year.(i)
  • Engrail Therapeutics's estimated revenue per employee is $201,000
  • Engrail Therapeutics's total funding is $221M.

Employee Data

  • Engrail Therapeutics has 41 Employees.(i)
  • Engrail Therapeutics grew their employee count by 46% last year.

Engrail Therapeutics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Technical OfficerReveal Email/Phone
3
VP, Corporate DevelopmentReveal Email/Phone
4
VP, BD and Commercial StrategyReveal Email/Phone
5
SVP Nonclinical Development, Head Pharmacokinetics and Drug MetabolismReveal Email/Phone
6
Director, Clinical OperationsReveal Email/Phone
7
Senior Director, CMCReveal Email/Phone
8
Chief Scientific OfficerReveal Email/Phone
9
Sr. Director Program ManagementReveal Email/Phone
10
Director, Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is Engrail Therapeutics?

We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.

keywords:N/A

$221M

Total Funding

41

Number of Employees

$8.2M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Engrail Therapeutics News

2022-03-22 - AgriLife Research continues quest for cure of Menkes Disease

Engrail Therapeutics, a neuroscience company focused on the acquisition, development and commercialization of patient-centric therapies,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M41N/AN/A
#2
$4.8M410%N/A
#3
$3.2M4128%$43M
#4
$8.2M4111%N/A
#5
$3.9M4111%N/A